Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex TOF-Watch vs PNS Comparison
NCT00535496Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2007
- Primary completion
- Jan 2008
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 3 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Merck & Co.. Started Sep 2007; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT00535496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535496.